Impact of Remote Vital Signs Monitoring in People Using Long-term Oxygen Therapy

Inclusion Criteria

• •Patients with a clinical, radiological and/or anatomopathological diagnosis of COPD and ILD according to the 2020 ATS/JRS/ALAT guidelines;
• •Age over 18 years;
• •Clinical stability (absence of exacerbations or hospitalizations related to the underlying disease) for at least 6 weeks;
• •Patients who are on optimized drug therapy, including long-term home oxygen therapy (LTOT)
• •Have a smartphone compatible with the monitoring device;
• •Signing of the ICF to participate in the study.